One of the out-patient rehab options for clients in Quincy who are struggling with opioid abuse and addiction is opioid maintenance therapy. Licensed clinics and doctors are authorized to dispense certain medications to opioid addicted clients, many of which are opioid-based themselves and are habit forming. In low enough amounts the user does not experience being high but also does not experience severe cravings and is not in opioid withdrawal. Methadone is the first drug tried for this sole purpose, but there are other choices currently to pick from.
Methadone is an opiate and is meant to be taken at an outpatient medical center certified to dispense the med, which is taken on a daily basis in liquid or pill form. The price of the drug is about $150 per month. Buprenorphine is also an opioid-based drug, and is a pill often taken every other day. But unlike Methadone that is only be dispensed in highly well-regulated clinics, Buprenorphine can be prescribed and administered in doctor's offices. The price monthly of buprenorphine is around $300 monthly for the generic of the drug. There is also a type of buprenorphine that contains naloxone, that is a drug which reverses the effects of opiates. A person taking this formulation, AKA Suboxone, would find it more difficult to feel high from opioids if they relapsed while taking the drug. It is also taken every day, and is priced about $450 a month. Naltrexone is an additional medication taken in opioid maintenance therapy, but unlike the other drugs mentioned here it's an opiate blocker and is not an opioid. A person has the choice to take this medication as a monthly injection, which is called Vivitrol. As an opioid blocker, it prevents an individual from experience high feelings from opioids, and in turn lowers the risk associated with relapse. This daily shot costs in the range of $1000 to $1200 per month.
There are 1 Drug and Alcohol Rehabilitation Facilities offering this service in Quincy, MA
For All Alcohol and Drug Rehabilitation Facilities In Quincy, Click Here.